Levels of Intestinal Inflammation and Fibrosis in Resection Specimens after Preoperative Anti-Tumor Necrosis Factor Alpha Treatment in Patients with Crohn’s Disease: A Comparative Pilot Study

Background. Strictures are a common complication in Crohn’s disease (CD), found in more than 50% of patients. They are characterized by the excessive deposition of extracellular proteins in the tissue as a result of the chronic inflammatory process. The effect of anti-tumor necrosis factor alpha (TN...

Full description

Bibliographic Details
Main Authors: J. Torle, P. D. Dabir, U. Korsgaard, J. Christiansen, N. Qvist, A. El-Hussuna
Format: Article
Language:English
Published: Hindawi Limited 2020-01-01
Series:Surgery Research and Practice
Online Access:http://dx.doi.org/10.1155/2020/6085678
id doaj-d6f2bb7f5eb142178ff01be7c826f717
record_format Article
spelling doaj-d6f2bb7f5eb142178ff01be7c826f7172020-11-25T00:28:45ZengHindawi LimitedSurgery Research and Practice2356-77592356-61242020-01-01202010.1155/2020/60856786085678Levels of Intestinal Inflammation and Fibrosis in Resection Specimens after Preoperative Anti-Tumor Necrosis Factor Alpha Treatment in Patients with Crohn’s Disease: A Comparative Pilot StudyJ. Torle0P. D. Dabir1U. Korsgaard2J. Christiansen3N. Qvist4A. El-Hussuna5Department of Surgery, Regional Hospital Randers, Midt-Jylland region, Randers, DenmarkDepartment of Pathology, Regional Hospital Randers, Midt-Jylland region, Randers, DenmarkDepartment of Pathology, Regional Hospital Randers, Midt-Jylland region, Randers, DenmarkDepartment of Pathology, Regional Hospital Randers, Midt-Jylland region, Randers, DenmarkIBD Care, Surgical Research Unit, Odense University Hospital, Southern University of Denmark, region Syd Danmark, Randers, DenmarkDepartment of Surgery, Aalborg University Hospital, Aalborg, Nord-Jylland region, DenmarkBackground. Strictures are a common complication in Crohn’s disease (CD), found in more than 50% of patients. They are characterized by the excessive deposition of extracellular proteins in the tissue as a result of the chronic inflammatory process. The effect of anti-tumor necrosis factor alpha (TNF-α) therapy on the development of fibrosis is not yet fully understood. Aim. To investigate whether the degree of intestinal inflammation and fibrosis is correlated with preoperative anti-TNF-α therapy in patients with CD who are undergoing bowel resection. Methods. This unblinded, prospective, single tertiary center, pilot cohort study included all adult patients with CD who underwent elective, laparoscopic, or open intestinal resection. Preoperative investigations included measurement of blood TNF-α concentration, specific antidrug antibodies, and the concentration of selected inflammatory cytokines. Three pathologists independently examined the specimens and assessed the degree of inflammation and fibrosis. Results. Histopathological specimens from 10 patients with CD who underwent ileocecal or ileocolic resections were retrieved. Four of those patients were on anti-TNF-α treatment prior to surgery. The last dose of the anti-TNF-α agent was administered 1–9 weeks prior to bowel resection. Patients on anti-TNF-α treatment had a higher fibrosis score than controls (p=0.01). Anti-TNF-α treatment was not associated with an increase in CD68- or CD163-positive macrophages. There was no significant relationship between the time from the final preoperative anti-TNF-α dose to surgery and the fibrosis score. No significant association was found between the concentration of major inflammatory cytokines, including TNF-α, and the fibrosis score or degree of inflammation. Conclusions. Patients who underwent preoperative anti-TNF-α treatment had a higher fibrosis score than controls.http://dx.doi.org/10.1155/2020/6085678
collection DOAJ
language English
format Article
sources DOAJ
author J. Torle
P. D. Dabir
U. Korsgaard
J. Christiansen
N. Qvist
A. El-Hussuna
spellingShingle J. Torle
P. D. Dabir
U. Korsgaard
J. Christiansen
N. Qvist
A. El-Hussuna
Levels of Intestinal Inflammation and Fibrosis in Resection Specimens after Preoperative Anti-Tumor Necrosis Factor Alpha Treatment in Patients with Crohn’s Disease: A Comparative Pilot Study
Surgery Research and Practice
author_facet J. Torle
P. D. Dabir
U. Korsgaard
J. Christiansen
N. Qvist
A. El-Hussuna
author_sort J. Torle
title Levels of Intestinal Inflammation and Fibrosis in Resection Specimens after Preoperative Anti-Tumor Necrosis Factor Alpha Treatment in Patients with Crohn’s Disease: A Comparative Pilot Study
title_short Levels of Intestinal Inflammation and Fibrosis in Resection Specimens after Preoperative Anti-Tumor Necrosis Factor Alpha Treatment in Patients with Crohn’s Disease: A Comparative Pilot Study
title_full Levels of Intestinal Inflammation and Fibrosis in Resection Specimens after Preoperative Anti-Tumor Necrosis Factor Alpha Treatment in Patients with Crohn’s Disease: A Comparative Pilot Study
title_fullStr Levels of Intestinal Inflammation and Fibrosis in Resection Specimens after Preoperative Anti-Tumor Necrosis Factor Alpha Treatment in Patients with Crohn’s Disease: A Comparative Pilot Study
title_full_unstemmed Levels of Intestinal Inflammation and Fibrosis in Resection Specimens after Preoperative Anti-Tumor Necrosis Factor Alpha Treatment in Patients with Crohn’s Disease: A Comparative Pilot Study
title_sort levels of intestinal inflammation and fibrosis in resection specimens after preoperative anti-tumor necrosis factor alpha treatment in patients with crohn’s disease: a comparative pilot study
publisher Hindawi Limited
series Surgery Research and Practice
issn 2356-7759
2356-6124
publishDate 2020-01-01
description Background. Strictures are a common complication in Crohn’s disease (CD), found in more than 50% of patients. They are characterized by the excessive deposition of extracellular proteins in the tissue as a result of the chronic inflammatory process. The effect of anti-tumor necrosis factor alpha (TNF-α) therapy on the development of fibrosis is not yet fully understood. Aim. To investigate whether the degree of intestinal inflammation and fibrosis is correlated with preoperative anti-TNF-α therapy in patients with CD who are undergoing bowel resection. Methods. This unblinded, prospective, single tertiary center, pilot cohort study included all adult patients with CD who underwent elective, laparoscopic, or open intestinal resection. Preoperative investigations included measurement of blood TNF-α concentration, specific antidrug antibodies, and the concentration of selected inflammatory cytokines. Three pathologists independently examined the specimens and assessed the degree of inflammation and fibrosis. Results. Histopathological specimens from 10 patients with CD who underwent ileocecal or ileocolic resections were retrieved. Four of those patients were on anti-TNF-α treatment prior to surgery. The last dose of the anti-TNF-α agent was administered 1–9 weeks prior to bowel resection. Patients on anti-TNF-α treatment had a higher fibrosis score than controls (p=0.01). Anti-TNF-α treatment was not associated with an increase in CD68- or CD163-positive macrophages. There was no significant relationship between the time from the final preoperative anti-TNF-α dose to surgery and the fibrosis score. No significant association was found between the concentration of major inflammatory cytokines, including TNF-α, and the fibrosis score or degree of inflammation. Conclusions. Patients who underwent preoperative anti-TNF-α treatment had a higher fibrosis score than controls.
url http://dx.doi.org/10.1155/2020/6085678
work_keys_str_mv AT jtorle levelsofintestinalinflammationandfibrosisinresectionspecimensafterpreoperativeantitumornecrosisfactoralphatreatmentinpatientswithcrohnsdiseaseacomparativepilotstudy
AT pddabir levelsofintestinalinflammationandfibrosisinresectionspecimensafterpreoperativeantitumornecrosisfactoralphatreatmentinpatientswithcrohnsdiseaseacomparativepilotstudy
AT ukorsgaard levelsofintestinalinflammationandfibrosisinresectionspecimensafterpreoperativeantitumornecrosisfactoralphatreatmentinpatientswithcrohnsdiseaseacomparativepilotstudy
AT jchristiansen levelsofintestinalinflammationandfibrosisinresectionspecimensafterpreoperativeantitumornecrosisfactoralphatreatmentinpatientswithcrohnsdiseaseacomparativepilotstudy
AT nqvist levelsofintestinalinflammationandfibrosisinresectionspecimensafterpreoperativeantitumornecrosisfactoralphatreatmentinpatientswithcrohnsdiseaseacomparativepilotstudy
AT aelhussuna levelsofintestinalinflammationandfibrosisinresectionspecimensafterpreoperativeantitumornecrosisfactoralphatreatmentinpatientswithcrohnsdiseaseacomparativepilotstudy
_version_ 1716163617492041728